Startups
YnoneYnone – Digital companion for lymphoedema therapy

Ynone helps people living with lymphoedema manage their daily therapy and bring structured, clear data to their healthcare team.

What we do
• Daily therapy routine: measurements, compression, skin care, movement and reminders in one place
• Structured reports for doctor's appointments, so care between visits becomes visible
• Ida, our AI assistant for self-management, available in five languages
• Ynone Scan (in development): smartphone-based limb measurement, on the path to MDR Class IIa certification

Where we are
• Beta app in usability testing with patients
• Collaborations with Charité, Földiklinik and Uniklinik Bonn
• Part of the Vision Health Pioneers incubator, Berliner Startup Stipendium

The opportunity
We're applying for the EXIST-Gründungsstipendium with a Charité mentor (planned start: April 2027). A new co-founder can join the founding team with a 12-month stipend and help build a medical device from day one.

www.ynone.eu
Social Media

Details

Customer Problem
Customer Problem Lymphoedema therapy happens mostly at home, every day, but care between visits is fragmented and invisible. Patients • Heavy daily routine with paper diaries and unreliable tape measurements • No clear way to see if the therapy is working • Delays in getting new compression garments Doctors • Little or no structured data between visits • Treatment decisions based on patients' memory and incomplete notes Manufacturers & medical supply companies • No direct, ongoing contact with the patients who use their products • Orders stall because of missing documents, outdated prescriptions or wrong sizes
Business Model
Business Model B2B2C: the app is free for patients, and companies that serve them pay for access. Manufacturers & medical supply companies (main revenue) • Annual partner packages: partner profile in the app and on the website, community visibility and reminders for garment and prescription renewals • A direct digital channel to the right patients Patients • Freemium: basic app free (routine, diary, reminders, measurements, Ida) • Premium: unlimited use of Ida and a personal document archive Next steps • Clinic licences after pilot projects • Selective contracts with health insurers (§ 140a SGB V) for free long-term access for patients
Technology Description
Technology Description Companion app • Web app (PWA) in beta, native app for iOS and Android (React Native) in development • Personalised daily routine, therapy diary, guided measurements, reminders and exportable care reports • Available in 3 languages Ida – AI assistant for self-management • Answers only from a curated lymphoedema knowledge base, never from general internet knowledge • Hybrid retrieval (semantic + full-text search) with large language models via Amazon Bedrock • Rule-based safety layers that redirect medical questions to healthcare professionals • 5 languages, tested with a domain-specific benchmark Ynone Scan – smartphone limb measurement (in development) • Two photos of the limb (front and side) with a standardised protocol • Computer vision detects limb outlines and estimates circumference at defined points • To be validated against tape measurements in a clinical study, then certified as a medical device (MDR Class IIa) Data protection • GDPR by design: EU hosting (Supabase, Hetzner), encryption, role-based access, data shared only with explicit consent
Market Description
Market Description Initial market: Germany • Adults and children with lymphoedema in conservative therapy, plus their caregivers • Care costs about €5,784 per patient per year, €3,796 of it paid by statutory health insurance • Germany is about 31% of the European lymphoedema treatment market, expected to grow 9.1% per year to $617.7 million by 2033 Paying customers • Manufacturers of compression garments and decongestion devices • Medical supply companies and stores (Sanitätshäuser) that deliver products to these patients Go-to-market • Through partner clinics (Charité, Földiklinik, Uniklinik Bonn, Lympho Opt Klinik), patient associations and communities • Target: 0.5% of German patients within four years, about 22,500 users Expansion • Europe after the German market is established • Later: lipoedema and other chronic conditions with similar daily self-management

Finance Data

DateInvestorsAmountStage 

Financial Overview

No revenue recorded yet

More details

Proximity of the idea to research

Is the business idea based directly on research results?

Founding idea in one sentence

Management hub for conservative lymphoedema therapy

IP-based

Is the business model based on intellectual property (IP)?

Patent available

Team diversity

MVP developed

Pilot customer available

Validated business model

Number of employees (after 12 months)

4